Bitte verwenden Sie diesen Link, wenn Sie dieses Dokument zitieren oder verlinken wollen: https://nbn-resolving.org/urn:nbn:de:gbv:9-opus-44808
Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)
Download full text files
Additional Services
Statistics
| Author: | Daniel Pink, Dimosthenis Andreou, Sebastian Bauer, Thomas Brodowicz, Bernd Kasper, Peter Reichardt, Stephan Richter, Lars H. Lindner, Joanna Szkandera, Viktor Grünwald, Maxim Kebenko, Marietta Kirchner, Peter Hohenberger |
|---|---|
| URN: | urn:nbn:de:gbv:9-opus-44808 |
| DOI: | https://doi.org/10.3390/cancers13061223 |
| ISSN: | 2072-6694 |
| Parent Title (English): | Cancers |
| Publisher: | MDPI |
| Document Type: | Article |
| Language: | English |
| Date of first Publication: | 2021/03/11 |
| Release Date: | 2021/06/10 |
| Tag: | angiosarcoma; efficacy; paclitaxel; pazopanib; progression-free survival; toxicity |
| GND Keyword: | - |
| Volume: | 13 |
| Issue: | 6 |
| Faculties: | Universitätsmedizin / Klinik und Poliklinik für Innere Medizin Abt. Nephrologie, Hochdruckkrankheiten und Dialyse |
| Licence (German): |  Creative Commons - Namensnennung |